Detalles de la búsqueda
1.
Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, following vaccination in children at 2, 4, 6 and at 15-18 months.
Vaccine
; 38(21): 3780-3789, 2020 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32273184
2.
Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14â¯weeks and 9â¯months of age.
Vaccine
; 38(3): 530-538, 2020 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31703934
Resultados
1 -
2
de 2
1
Próxima >
>>